Researchers would love if they can expand time to fit in that publication, article, or review of their topic of interest; if that were true, however, there is no end to bottomless scrolling and missing the important details. PubReading would read out the abstract, results, and discussions to allow hassle-free information and a chance to create connections with like-minded individuals.
Podcast Overview
Researchers would love if they can expand time to fit in that publication, article, or review of their topic of interest; if that were true, however, there is no end to bottomless scrolling and missing the important details. PubReading would read out the abstract, results, and discussions to allow hassle-free information and a chance to create connections with like-minded individuals.
Language
🇺🇲
Publishing Since
7/17/2021
Reach the team behind PubReading
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
July 3, 2023
PubReading [346] - Transparency Is the Key to Quality - A. Fosang & R. Colbran
A workshop held last June by the National Institutes of Health (NIH) Director’s Office, Nature Publishing Group, and Science focused on the role that <strong>journals</strong> play in supporting<strong> scientific research</strong> that is reproducible, robust, and transparent. The “Principles and Guidelines for Reporting <strong>Preclinical Research</strong>” that emerged from the workshop have since been endorsed by nearly 80 societies, journals, and associations.VOL.290,NO.50,pp.29692–29694 - 2015
June 26, 2023
PubReading [343] - The changing career trajectories of new parents in STEM - E. Cech & M. Blair-Loy
<p>The <strong>gender</strong> imbalance in <strong>science</strong>, <strong>technology</strong>, <strong>engineering</strong>, and <strong>math</strong> (STEM) fields has remained constant for decades and increases the farther up the STEM career pipeline one looks. Why does the underrepresentation of women endure? This study investigated the role of parenthood as a mechanism of gender-differentiated attrition from STEM employment. Using a nationally representative 8-year longitudinal sample of US STEM professionals, we examined the career trajectories of new parents after the birth or adoption of their first child. We found substantial attrition of new <strong>mothers</strong>: 43% of women leave full-time <strong>STEM employment</strong> after their first child. New mothers are more likely than new <strong>fathers</strong> to leave STEM, to switch to part-time work, and to exit the labor force. These gender differences hold irrespective of variation by discipline, race, and other demographic factors. However, parenthood is not just a “mother’s problem”; 23% of new fathers also leave STEM after their first child. Suggesting the difficulty of combining STEM work with caregiving responsibilities generally, new parents are more likely to leave full-time STEM jobs than otherwise similar childless peers and even new parents who remain employed full time are more likely than their childless peers to exit STEM for work elsewhere. These results have implications for<strong> policymakers</strong> and STEM workforce scholars; whereas <strong>parenthood</strong> is an important mechanism of women’s attrition, both women and men leave at surprisingly high rates after having children. Given that most people become parents during their working lives, STEM fields must do more to retain professionals with children.doi/10.1073/pnas.1810862116 - 2019</p>
June 21, 2023
PubReading [341] - Carbon Nanomaterials (CNMs) in Cancer Therapy- A Database of CNM-Based Nanocarrier Systems - H. Mohan, A. Fagan & S. Giordani
<strong>Carbon nanomaterials</strong> (CNMs) are an incredibly versatile class of materials that can be used as scaffolds to construct <strong>anticancer</strong> nanocarrier systems. The ease of chemical functionalisation, <strong>biocompatibility</strong>, and intrinsic therapeutic capabilities of many of these nanoparticles can be leveraged to design effective anticancer systems. This article is the first comprehensive review of CNM-based nanocarrier systems that incorporate approved chemotherapy drugs, and many different types of <strong>CNM</strong>s and <strong>chemotherapy</strong> agents are discussed. Almost 200 examples of these nanocarrier systems have been analysed and compiled into a database. The entries are organised by anticancer drug type, and the composition, drug loading/release metrics, and experimental results from these systems have been compiled. Our analysis reveals graphene, and particularly graphene oxide (GO), as the most frequently employed CNM, with <strong>carbon nanotubes</strong> and <strong>carbon dots</strong> following in popularity. Moreover, the database encompasses various chemotherapeutic agents, with antimicrotubule agents being the most common payload due to their compatibility with CNM surfaces. The benefits of the identified systems are discussed, and the factors affecting their efficacy are detailed.<a href="http://doi.org/10.3390/pharmaceutics15051545">doi.org/10.3390/pharmaceutics15051545</a> - 2023
343 total episodes available
Deep-dive analytics for PubReading
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is PubReading?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.